DOI: http://dx.doi.org/10.18203/issn.2454-5929.ijohns20195690

Primary surgery for locoregional advanced oropharyngeal cancer: prognostic factors

Patrícia S. Gomes, Eduardo Breda, Eurico Monteiro

Abstract


Background: Oropharyngeal squamous cell carcinoma (OPSCC) incidence is rising in developed countries. These malignancies usually present in advanced stages and are associated with poor outcome. This work aims to ascertain the clinical and histopathological prognostic factors of locoregional advanced OPSCC treated with primary surgery in a tertiary oncology centre.

Methods: Retrospective chart review of all patients with advanced OPSCC who underwent primary surgery from 2011 to 2016. Overall and disease-free survivals were estimated using Kaplan-Meier method. Clinical and histopathological prognostic factors were determined by univariate (Log Rank tests) and multivariate (Cox models) analyses.  

Results: 89 patients (89.9% male) with a mean age of 57.6±10.0 years were included in the study. Five-year overall and disease-free survivals were 53.9% and 57.7%, respectively. Pathologic N stage (HR=2.65 95% IC 1.32-5.32, p<0.01), distant metastasis (HR= 3.26 95% IC 1.24-8.62, p=0.01) and postoperative radiotherapy (HR=0.02 95% IC 0.01-0.12, p<0.01) were significantly correlated with overall survival. Pathologic N stage (HR=2.41, 95% IC 1.04-5.63, p=0.04) perineural infiltration (2.45, 95% IC 1.01-5.95 p=0.04), distant metastasis (HR=5.24, 95% IC 2.31-11.89, p<0.01) and postoperative radiotherapy (HR=0.02 95% IC 0.00-0.18, p<0.01), were significantly correlated with locoregional disease-free survival.

Conclusions: Knowledge of survival prognostic factors is crucial for selection of the appropriate treatment of oropharyngeal cancer. Pathological nodal stage, postoperative radiotherapy and the occurrence of distant metastasis were the main prognostic factors for overall and disease-free survivals in the present series. These findings may help to provide proper stratification in future randomized trials.


Keywords


Oropharynx, Prognosis, Squamous cell carcinoma, Surgery, Survival

Full Text:

PDF

References


Ang KK, Sturgis EM. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin Radiat Oncol. 2012;22:128-42.

Näsman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral‐induced carcinoma?. Int J Cancer. 2009;125(2):362-6.

Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin. 2017;67:93-9.

National Comprehensive Cancer Network. Head and neck cancers, version 1.2019. Available at: https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf. Accessed on 25 March 2019.

Cerezo L, Millan I, Torre A, Aragon G, Otero J. Prognostic factors for survival and tumour control in cervical lymph node metastases from head and neck cancer: a multivariate study of 492 cases. Cancer. 1992;69:1224-34.

Roberts TJ, Colevas AD, Hara W, Holsinger FC, Oakley-Girvan I, Divi V. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas. Cancer. 2016;122:1388-97.

Fujiwara RJT, Judson BL, Yarbrough WG, Husain Z, Mehra S. Treatment delays in oral cavity squamous cell carcinoma and association with survival. Head Neck. 2017;39:639-46.

Bastit L, Blot E, Debourdeau P, Menard J, Bastit P, Le Fur R. Influence of the delay of adjuvant postoperative radiation therapy on relapse and survival in oropharyngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys. 2001;49:139-46.

Schneider IJ, Flores ME, Nickel DA, Martins LG, Traebert J. Survival rates of patients with cancer of the lip, mouth and pharynx: a cohort study of 10 years. Rev Bras Epidemiol. 2014;17:680-91.

Oliveira LR, Ribeiro-Silva A, Costa JP, Simões AL, Matteo MA, Zucoloto S. Prognostic factors and survival analysis in a sample of oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106:685-95.

Platek AJ, Jayaprakash V, Merzianu M, Platek ME, Cohan DM, Hicks WL, et al. Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation. Laryngoscope. 2016;126:2733-8.

Liskamp CP, Janssens GO, Bussink J, Melchers WJ, Kaanders JH, Verhoef CG. Adverse effect of smoking on prognosis in human papillomavirus-associated oropharyngeal carcinoma. Head Neck. 2016;38(12):1780-7.

Nixon IJ, Palmer FL, Lakin P, Kattan MM, Lee NY, Ganly I. Pathologically determined tumour volume vs pathologic T stage in the prediction of outcome after surgical treatment of oropharyngeal squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2013;139:1151-5.

Agarwal JP, Mallick I, Bhutani R, Ghosh-Laskar S, Gupta T, Budrukkar A, et al. Prognostic factors in oropharyngeal cancer-analysis of 627 cases receiving definitive radiotherapy. Acta Oncol. 2009;48:1026-33.

Robbins KT, Asteriors T, Suárez C, López F, Hunt JL, Strojan P, et al. Surgical margins in head and neck cancer: Intra and postoperative considerations. Auris Nasus Larynx. 2019;46:10-7.

Molony P, Kharytaniuk N, Boylee S, Woods RSR, O’leary G, Werner R, et al. Impact of positive margins on outcomes of oropharyngeal squamous cell carcinoma according to p16 status. Head Neck. 2017;39:1680-8.

Kurita H, Nakanishi Y, Nishizawa R, Xiao T, Kamata T, Koike T, et al. Impact of different surgical margin conditions on local recurrence of oral squamous cell carcinoma. Oral Oncol. 2010;46:814-7.

McMahon J, O’Brien CJ, Pathak I, Hamill R, McNeil E, Hammersley N, et al. Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer. Br J Oral Maxillofac Surg. 2003;41:224-31.

Iyer NG, Dogan S, Palmer F, Rahmati R, Nixon IJ, Lee N, et al. Detailed analysis of clinicopathologic factors demonstrate distinct difference in outcome and prognostic factors between surgically treated HPV-positive and negative oropharyngeal cancer. Ann Surg Oncol. 2015;22:4411-21.

Shimizu K, Inoue H, Saitoh M, Ohtsuki N, Ishida H, Makino K, et al. Distribution and impact of lymph node metastases in oropharyngeal cancer. Acta Otolaryngol. 2006;126:872-7.

Preuss SF, Dinh V, Klussmann JP, Semrau R, Mueller RP, Guntinas-Lichius O. Outcome of multimodal treatment for oropharyngeal carcinoma: a single institution experience. Oral Oncol. 2007;43:402-7.

De Matos FR, Lima E, Queiroz LM, da Silveira EJ. Analysis of Inflammatory Infiltrate, Perineural Invasion, and Risk Score Can Indicate Concurrent Metastasis in Squamous Cell Carcinoma of the Tongue. J Oral Maxillofac Surg. 2012;70:1703-10.

Miller EM, Palla B, Chen Q, Elashoff AD, Abemayor E, St John MA, et al. A novel classification system for perineural invasion in noncutaneous head and neck squamous cel carcinoma: histologic subcategories and patient outcomes. Am J Otolaryngol. 2012;33:212-5.

McBride SM, Busse PM, Clark JR, Wirth LJ, Ancukiewicz M, Chan AW. Long-term survival after distant metastasis in patients with oropharyngeal cancer. Oral Oncol. 2014;50:208-12.

Huang SH, Perez-Ordonez B, Weinreb I, Hope A, Massey C, Waldron JN, et al. Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral Oncol. 2013;49:79-85.